T/JPMA 023-2024 Active Group standards

T/JPMA 023-2024 Vaccine clinical trial safety follow-up work specification

T/JPMA 023-2024 Vaccine clinical trial safety follow-up work specification

Publish Date: 2024-09-02 Implement Date: 2024-09-09 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/JPMA 023-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine, health, and labor protection
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2024-09-02
Implement Date: 2024-09-09

Scope

Main technical content: This document specifies the main content and working procedures of safety follow-up work for subjects after immunization in vaccine clinical trials. This document is applicable to the follow-up work on adverse events of subjects after immunization in vaccine clinical trials.

Development Information

Related Standards

Contact Us